Vitamin D: Skeletal and muscular effects;Effets osseux et musculaires de la vitamine D

Presse Medicale

Volumn 42, Issue 10, 2013, Pages 1351-1357

  Thomas, Thierry ^a   Briot, Karine ^b  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b Service de rhumatologie ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D; VITAMIN D RECEPTOR;

BONE REMODELING; FALL RISK; FRACTURE; HUMAN; MUSCLE FUNCTION; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; RISK FACTOR; RISK REDUCTION; SHORT SURVEY; SKELETAL MUSCLE; VITAMIN BLOOD LEVEL;

ACCIDENTAL FALLS; ANIMALS; BONE AND BONES; FRACTURES, BONE; HUMANS; MUSCLE, SKELETAL; MUSCULOSKELETAL PAIN; OSTEOPOROSIS; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84886284788     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2013.07.008     Document Type: Short Survey

References (60)

1. Chapuy M.C., Preziosi P., Maamer M., Arnaud S., Galan P., Hercberg S., et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997, 7:439-443.
2. Briot K., Audran M., Cortet B., Fardellone P., Marcelli C., Orcel P., et al. Vitamine D: effet osseux et extra-osseux; recommandations de bon usage. Presse Med 2009, 38:43-54.
3. Annweiler C., Schott A.M., Allali G., Bridenbaugh S.A., Kressig R.W., Allain P., et al. Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 2010, 74:27-32.
4. Visser M., Deeg D.J., Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the longitudinal aging study Amsterdam. J Clin Endocrinol Metab 2003, 88:5766-5772.
5. Flicker L., Mead K., MacInnis R.J., Nowson C., Scherer S., Stein M.S., et al. Serum Vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 2003, 51:1533-1538.
6. Schmidlin S., Bioteau C., Detavernier M., Couturier P., Gavazzi G. Prévalence de l'hypovitaminose D chez les patients âgés hospitalisés en clinique de gériatrie. Presse Med 2010, 39:271-272.
7. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Stuck A.E., Staehelin H.B., Orav E.J., et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009, 169:551-561.
8. Bischoff-Ferrari H.A., Giovannucci E., Willett W.C., Dietrich T., Dawson-Hugues B. Estimation of optimal serum concentrations of 250HD for multiple health outcomes. Am J Clin Nutr 2006, 84:18-28.
9. Heaney R.P., Dowell M.S., Hale C.A., Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003, 22:142-146.
10. Amouzougan A., Chopin F., Laporte S., Vico L., Thomas T. Functional hypoparathyroidism in postmenopausal women with fragility fracture. Joint Bone Spine 2012, 79:170-175.
11. Need A.G., O'Loughlin P.D., Morris H.A., Coates P.S., Horowitz M., Nordin B.E., et al. metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res 2008, 23:1859-1863.
12. Rizzoli R., Bianchi M.L., Garabedian M., McKay H.A., Moreno L.A. Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly. Bone 2010, 46:294-305.
13. Bischoff-Ferrari H.A., Willett W.C., Wong J.B., Giovannucci E., Dietrich T., Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005, 293:2257-2264.
14. Anderson P.H., Atkins G.J., Turner A.G., Kogawa M., Findlay D.M., Morris H.A. Vitamin D metabolism within bone cells: effects on bone structure and strength. Mol Cell Endocrinol 2011, 347:42-47.
15. Tang B.M.P., Eslick G.D., Nowson C., Smith C., Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50years and older: a meta-analysis. Lancet 2007, 370:657-666.
16. Trivedi D.P., Doll R., Khaw K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326:469-475.
17. Chapuy M.C., Arlot M.E., Duboeuf F., Brun J., Crouzet B., Arnaud S., et al. Vitamin D3and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992, 327:1637-1642.
18. Grant A.M., Avenell A., Campbell M.K., McDonald A.M., MacLennan G.S., McPherson G.C., et al. Oral vitamin D3and calcium for secondary prevention of low-trauma fractures in elderly people (randomized evaluation of calcium or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005, 365:1621-1628.
19. Bischoff-Ferrari H.A. How to select the doses of vitamin D in the management of osteoporosis. Osteoporos Int 2007, 18:401-407.
20. Bischoff-Ferrari H.A., Willett W.C., Orav E.J., Lips P., Meunier P.J., Lyons R.A., et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012, 367:40-49.
21. Bischoff-Ferrari H.A., Dawson-Hughes B., Baron J.A., Burckhardt P., Li R., Spiegelman D., et al. Calcium intake and hip fracture risk in men and women: a metaanalysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr 2007, 86:1780-1790.
22. Sanders K.M., Stuart A.L., Williamson E.J., Simpson J.A., Kotowicz M.A., Young D., et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010, 303:1815-1822. [Erratum, JAMA 2010;303:2357].
23. Smith H., Anderson F., Raphael H., Maslin P., Crozier S., Cooper C. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women - a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) 2007, 46:1852-1857.
24. Briot K., Cortet B., Thomas T., Audran M., Blain H., Breuil V., et al. 2012update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis. Joint Bone Spine 2012, 79:304-313.
25. Adami S., Giannini S., Bianchi G., Sinigagklia L., Di Munno O., Fiore C.E., et al. Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int 2009, 20:239-244.
26. Olmos J.M., Hernández J.L., Llorca J., Nan D., Valero C., González-Macías J. Effects of 25-hydroxyvitamin D3therapy on bone turnover markers and PTH levels in postmenopausal osteoporotic women treated with alendronate. J Clin Endocrinol Metab 2012, 97:4491-4497.
27. Selles J., Boland R. Evidence on the participation of the 3',5'-cyclic AMP pathway in the non-genomic action of 1,25-dihydroxy-vitamin D3in cardiac muscle. Mol Cell Endocrinol 1991, 82:229-235.
28. Al-Said Y.A., Al-Rached H.S., Al-Qahtani H.A., Jan M.M. Severe proximal myopathy with remarkable recovery after vitamin D treatment. Can J Neurol Sci 2009, 36:336-339.
29. Bischoff-Ferrari H.A., Borchers M., Gudat F., Dürmuller U., Stâhelin H.B., Dick W. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 2004, 19:265-269.
30. Boxer R.S., Dauser D.A., Walsh S.J., Hager W.D., Kenny A.M. The association between vitamin D and inflammation with the 6-minute walk and frailty in patients with heart failure. J Am Geriatr Soc 2008, 56:454-546.
31. Mastaglia S.R., Seijo M., Muzio D., Somoza J., Nuñez M., Oliveri B. Effect of vitamin D nutritional status on muscle function and strength in healthy women aged over sixty-five years. J Nutr Health Aging 2011, 15:349-354.
32. Annweiler C., Schott A.M., Berrut G., Fantino B., Beauchet O. Vitamin D-related changes in physical performance: a systematic review. J Nutr Health Aging 2009, 13:893-898.
33. Bischoff-Ferrari H.A., Dietrich T., Orav E.J., Hu F.B., Zhang Y., Karlson E.W., et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged ≥60y. Am J Clin Nutr 2004, 80:752-758.
34. Pfeifer M., Begerow B., Minne H.W., Suppan K., Fahrleitner-Pammer A., Dobnig H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int 2009, 20:315-322.
35. Zhu K., Austin N., Devine A., Bruce D., Prince R.L. A randomized controlled trial of the effects of vitamin D on muscle strength and mobility in older women with vitamin D insufficiency. J Am Geriatr Soc 2010, 58:2063-2068.
36. Glendenning P., Zhu K., Inderjeeth C., Howat P., Lewis J.R., Prince R.L. Effects of three monthly oral 150,000IU cholecalciferol supplementation on falls, mobility and muscle strength in older postmenopausal women: a randomised controlled trial. J Bone Miner Res 2012, 27(1):170-176.
37. Latham N.K., Anderson C.S., Lee A., Bennett D.A., Moseley A., Cameron I.D. A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the Frailty Interventions Trial in Elderly Subjects (FITNESS). J Am Geriatr Soc 2003, 51:291-299.
38. Kukuljan S., Nowson C.A., Sanders K., Daly R.M. Effects of resistance exercise and fortified milk on skeletal muscle mass, muscle size, and functional performance in middle-aged and older men: an 18-months randomized controlled trial. J Appl Physiol 2009, 07:1864-1873.
39. Muir S.W., Montero-Odasso M. Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 2011, 59:2291-2300.
40. Stockton K.A., Mengersen K., Paratz J.D., Kandiah D., Bennell K.L. Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int 2011, 22:859-871.
41. Snijder M.B., van Schoor N.M., Pluijm S.M., van Dam R.M., Visser M., Lips P. Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 2006, 91:2980-2985.
42. Sato Y., Iwamoto J., Kanoko T., Satoh K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 2005, 20:187-192.
43. Broe K.E., Chen T.C., Weinberg J., Bischoff-Ferrari H.A., Holick M.F., Kiel D.P. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007, 55:234-239.
44. Prince R.L., Austin N., Devine A., Dick I.M., Bruce D., Zhu K. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med 2008, 168:103-108.
45. Murad M.H., Elamin K.B., Abu Elnour N.O., Elamin M.B., Alkatib A.A., Fatourechi M.M. The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011, 96:2997-3006.
46. McBeth J., Pye S.R., O'Neill T.W., Macfarlane G.J., Tajar A., Bartfai G., et al. Musculoskeletal pain is associated with very low levels of vitamin D in men: results from the European Male Ageing Study. Ann Rheum Dis 2010, 69:1448-1452.
47. Warner A.E., Arnspiger S.A. Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J Clin Rheumatol 2008, 14:12-16.
48. Atherton K., Berry D.J., Parsons T., Macfarlane G.J., Power C., Hyppönen E. Vitamin D and chronic widespread pain in a white middle-aged British population: evidence from a cross-sectional population survey. Ann Rheum Dis 2009, 68:817-822.
49. Arvold D.S., Odean M.J., Dornfeld M.P., Regal R.R., Arvold J.G., Karwoski G.C. Correlation of symptoms with vitamin D deficiency and symptom response to cholecalciferol treatment: a randomized controlled trial. Endocr Pract 2009, 15:203-212.
50. Khan Q.J., Reddy P.S., Kimler B.F., Sharma P., Baxa S.E., O'Dea A.P. Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 2010, 119:111-118.
51. Rastelli A.L., Taylor M.E., Gao F., Armamento-Villareal R., Jamalabadi-Majidi S., Napoli N. Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial. Breast Cancer Res Treat 2011, 129:107-116.
52. Ahmed W., Khan N., Glueck C.J., Pandey S., Wang P., Goldenberg N. Low serum 25 (OH) vitamin D levels (<32ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res 2009, 153:11-16.
53. Glueck C.J., Budhani S.B., Masineni S.S., Abuchaibe C., Khan N., Wang P., et al. Vitamin D deficiency, myositis-myalgia, and reversible statin intolerance. Curr Med Res Opin 2011, 27:1683-1690.
54. Gupta R.P., Hollis B.W., Patel S.B., Patrick K.S., Bell N.H. CYP3A4is a human microsomal vitamin D 25-hydroxylase. J Bone Miner Res 2004, 19:680-688.
55. Poole A.R., Nelson F., Hollander A., Reiner A., Pidoux I., Ionescu M. Collagen II turnover in joint diseases. Acta Orthop Scand 1995, 266:88-91.
56. McAlindon T.E., Felson D.T., Zhang Y., Hannan M.T., Aliabadi P., Weissman B. Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study. Ann Intern Med 1996, 125:353-359.
57. Lane N.E., Gore L.R., Cummings S.R., Hochberg M.C., Scott J.C., Williams E.N. Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Study of osteoporotic fractures. Arthritis Rheum 1999, 42:854-860.
58. Felson D.T., Niu J., Clancy M., Aliabadi P., Sack B., Guermazi A. Low levels of vitamin D and worsening of knee osteoarthritis. Results of two longitudinal studies. Arthritis Rheum 2007, 56:129-136.
59. McAlindon T., LaValley M., Schneider E., Nuite M., Lee J.Y., Price L.L., et al. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA 2013, 309:155-162.
60. Benhamou C.L., Souberbielle J.C., Cortet B., Fardellone P., Gauvain J.B., Thomas T., et al. La vitamine D chez l'adulte: recommandations du GRIO. Press Med 2011, 40:673-682.